MEREO BIOPHARMA GROUP PLC Increase Decrease Through Other Changes Liabilities Arising From Financing Activities
MEREO BIOPHARMA GROUP PLC (MREO) reported Increase Decrease Through Other Changes Liabilities Arising From Financing Activities of GBP 251.00 thousand for the 12-month period ending 2018-12-31, per its 20-F filed 2020-06-15.
Discontinued › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities · last filed 2020-06-15
| Period end | Increase Decrease Through Other Changes Liabilities Arising From Financing Activities 12 month |
|---|---|
| 2018-12-31 | 251.00K GBP 20-F · filed 2020-06-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |